Literature DB >> 12675839

Atypical familial juvenile hyperuricemic nephropathy associated with a hepatocyte nuclear factor-1beta gene mutation.

Coralie Bingham1, Sian Ellard, William G van't Hoff, H Anne Simmonds, Anthony M Marinaki, Michael K Badman, Peter H Winocour, Amanda Stride, Christopher R Lockwood, Anthony J Nicholls, Katharine R Owen, Ghislaine Spyer, Ewan R Pearson, Andrew T Hattersley.   

Abstract

BACKGROUND: Familial juvenile hyperuricemic nephropathy (FJHN) is a dominantly inherited condition characterized by young-onset hyperuricemia, gout, and renal disease. The etiologic genes are unknown, although a locus on chromosome 16 has been identified in some kindreds. Mutations in the gene encoding hepatocyte nuclear factor (HNF)-1beta have been associated with dominant inheritance of a variety of disorders of renal development, particularly renal cystic disease and early onset diabetes; hyperuricemia has been reported in some kindreds.
METHODS: To assess a possible role for the HNF-1beta gene in some FJHN kindreds we sequenced the HNF-1beta gene in subjects from three unrelated FJHN families with atypical features of renal cysts or abnormalities of renal development. We also compared serum urate levels in subjects with HNF-1beta mutations with populations of controls, type 2 diabetic subjects, and subjects with mild chronic renal failure without HNF-1beta mutations.
RESULTS: A splice-site mutation in intron 2, designated IVS2+1G>T, showed complete co-segregation with FJHN in one family with diabetes. Serum urate levels were significantly higher in the HNF-1beta subjects compared with the normal control subjects (384 micromol/L vs. 264 micromol/L, P = 0.002) and the type 2 diabetic subjects (397 micromol/L vs. 271 micromol/L, P = 0.01). Comparison of serum urate levels in the HNF-1beta subjects with gender-matched subjects with renal impairment of other causes did not reach significance (402 micromol/L vs. 352 micromol/L, P = 0.2).
CONCLUSION: Hyperuricemia and young-onset gout are consistent features of the phenotype associated with HNF-1beta mutations, but the mechanism is uncertain. Families with HNF-1beta mutations may fit diagnostic criteria for FJHN. Identification of HNF-1beta patients by recognizing the features of diabetes and disorders of renal development is important in resolving the genetic heterogeneity in FJHN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675839     DOI: 10.1046/j.1523-1755.2003.00903.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  45 in total

1.  Identification of a new case of hepatocyte nuclear factor-1beta mutation with highly varied phenotypes.

Authors:  N Shihara; Y Horikawa; T Onishi; M Ono; K Kashimada; J Takeda
Journal:  Diabetologia       Date:  2004-05-28       Impact factor: 10.122

Review 2.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

Review 3.  Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes.

Authors:  Jacobien C Verhave; Anneke P Bech; Jack F M Wetzels; Tom Nijenhuis
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

Review 4.  Genetic testing in renal disease.

Authors:  Detlef Bockenhauer; Alan J Medlar; Emma Ashton; Robert Kleta; Nick Lench
Journal:  Pediatr Nephrol       Date:  2011-05-27       Impact factor: 3.714

5.  Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure.

Authors:  Graham D Smith; Caroline Robinson; Andrew P Stewart; Emily L Edwards; Hannah I Karet; Anthony G W Norden; Richard N Sandford; Fiona E Karet Frankl
Journal:  Clin J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 8.237

6.  Genetic basis of prune belly syndrome: screening for HNF1β gene.

Authors:  Candace F Granberg; Steven M Harrison; Daniel Dajusta; Shaohua Zhang; Sachin Hajarnis; Peter Igarashi; Linda A Baker
Journal:  J Urol       Date:  2011-11-23       Impact factor: 7.450

7.  Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

Authors:  Guillaume Bollée; Karin Dahan; Martin Flamant; Vincent Morinière; Audrey Pawtowski; Laurence Heidet; Didier Lacombe; Olivier Devuyst; Yves Pirson; Corinne Antignac; Bertrand Knebelmann
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 8.237

8.  Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome.

Authors:  L W Harries; S Ellard; R W A Jones; A T Hattersley; C Bingham
Journal:  Diabetologia       Date:  2004-04-15       Impact factor: 10.122

9.  HNF1B mutations associate with hypomagnesemia and renal magnesium wasting.

Authors:  Shazia Adalat; Adrian S Woolf; Karen A Johnstone; Andrea Wirsing; Lorna W Harries; David A Long; Raoul C Hennekam; Sarah E Ledermann; Lesley Rees; William van't Hoff; Stephen D Marks; Richard S Trompeter; Kjell Tullus; Paul J Winyard; Janette Cansick; Imran Mushtaq; Harjeeta K Dhillon; Coralie Bingham; Emma L Edghill; Rukshana Shroff; Horia Stanescu; Gerhart U Ryffel; Sian Ellard; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

10.  HNF1B-related diabetes triggered by renal transplantation.

Authors:  Julien Zuber; Christine Bellanné-Chantelot; Claire Carette; Guillaume Canaud; Sandrine Gobrecht; Khaled Gaha; Vincent Mallet; Frank Martinez; Eric Thervet; José Timsit; Christophe Legendre; Danièle Dubois-Laforgue
Journal:  Nat Rev Nephrol       Date:  2009-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.